Agilent Technologies acquires Biocare Medical
Agilent Technologies agreed to acquire Biocare Medical. Reported deal value: $950M. Status: Announced. Sector: Life sciences. Target headquarters context: Pacheco, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-11. Figures and status may change as filings and press coverage update.
Agilent to acquire Biocare in $ 950M ' complementary combination ' By Mar 11, 2026 3:00pm contract research organization mergers and acquisitions antibodies Biotech Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical , a pathology solutions business, in an all-cash transaction valued at $950 million
Deal timeline
This transaction is classified in Life sciences with a reported deal value of $950M. Figures and status may change as sources update.